Stephanie Schalm

Stephanie Schalm

Company: Kymera Therapeutics

Job title: Senior Director - Oncology


Seminar: Discovery of a First-In-Class MDM2 Degrader for the Treatment of Relapsed/Refractory TP-53 Wt AML & Solid Tumors 

For more information on this session, please download the full event guide.

Day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.